Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Generation and Characterization of Novel Cytochrome P450 Cyp2c Gene Cluster Knockout and CYP2C9 Humanized Mouse Lines

Nico Scheer, Yury Kapelyukh, Lynsey Chatham, Anja Rode, Sandra Buechel and C. Roland Wolf
Molecular Pharmacology December 2012, 82 (6) 1022-1029; DOI: https://doi.org/10.1124/mol.112.080036
Nico Scheer
TaconicArtemis, Koeln, Germany (N.S., A.R., S.B.); CXR Biosciences Limited, Dundee, United Kingdom (Y.K., C.R.W.); Cancer Research UK Molecular Pharmacology Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom (C.R.W.); and Division of Cancer Research, Medical Research Institute, Level 9, Jacqui Wood Cancer Centre, Ninewells Hospital & Medical School, University of Dundee, Dundee, United Kingdom (L.C.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yury Kapelyukh
TaconicArtemis, Koeln, Germany (N.S., A.R., S.B.); CXR Biosciences Limited, Dundee, United Kingdom (Y.K., C.R.W.); Cancer Research UK Molecular Pharmacology Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom (C.R.W.); and Division of Cancer Research, Medical Research Institute, Level 9, Jacqui Wood Cancer Centre, Ninewells Hospital & Medical School, University of Dundee, Dundee, United Kingdom (L.C.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lynsey Chatham
TaconicArtemis, Koeln, Germany (N.S., A.R., S.B.); CXR Biosciences Limited, Dundee, United Kingdom (Y.K., C.R.W.); Cancer Research UK Molecular Pharmacology Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom (C.R.W.); and Division of Cancer Research, Medical Research Institute, Level 9, Jacqui Wood Cancer Centre, Ninewells Hospital & Medical School, University of Dundee, Dundee, United Kingdom (L.C.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anja Rode
TaconicArtemis, Koeln, Germany (N.S., A.R., S.B.); CXR Biosciences Limited, Dundee, United Kingdom (Y.K., C.R.W.); Cancer Research UK Molecular Pharmacology Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom (C.R.W.); and Division of Cancer Research, Medical Research Institute, Level 9, Jacqui Wood Cancer Centre, Ninewells Hospital & Medical School, University of Dundee, Dundee, United Kingdom (L.C.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Buechel
TaconicArtemis, Koeln, Germany (N.S., A.R., S.B.); CXR Biosciences Limited, Dundee, United Kingdom (Y.K., C.R.W.); Cancer Research UK Molecular Pharmacology Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom (C.R.W.); and Division of Cancer Research, Medical Research Institute, Level 9, Jacqui Wood Cancer Centre, Ninewells Hospital & Medical School, University of Dundee, Dundee, United Kingdom (L.C.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Roland Wolf
TaconicArtemis, Koeln, Germany (N.S., A.R., S.B.); CXR Biosciences Limited, Dundee, United Kingdom (Y.K., C.R.W.); Cancer Research UK Molecular Pharmacology Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom (C.R.W.); and Division of Cancer Research, Medical Research Institute, Level 9, Jacqui Wood Cancer Centre, Ninewells Hospital & Medical School, University of Dundee, Dundee, United Kingdom (L.C.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 82 no. 6 1022-1029
DOI 
https://doi.org/10.1124/mol.112.080036
PubMed 
22918969

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received May 25, 2012
  • Accepted August 23, 2012
  • Published online November 14, 2012.

Article Versions

  • Earlier version (August 23, 2012 - 11:27).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2012 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Nico Scheer,
  2. Yury Kapelyukh,
  3. Lynsey Chatham,
  4. Anja Rode,
  5. Sandra Buechel, and
  6. C. Roland Wolf
  1. TaconicArtemis, Koeln, Germany (N.S., A.R., S.B.); CXR Biosciences Limited, Dundee, United Kingdom (Y.K., C.R.W.); Cancer Research UK Molecular Pharmacology Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom (C.R.W.); and Division of Cancer Research, Medical Research Institute, Level 9, Jacqui Wood Cancer Centre, Ninewells Hospital & Medical School, University of Dundee, Dundee, United Kingdom (L.C.).
  1. Address correspondence to:
    Dr. Nico Scheer, TaconicArtemis, Neurather Ring 1, 51063 Koeln, Germany. E-mail: nico.scheer{at}taconicartemis.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2012 to February 2023

AbstractFullPdf
Aug 2012106031
Sep 2012860104
Oct 201237066
Nov 20124952377
Dec 20124461451
Jan 20131611936
Feb 2013106916
Mar 201385630
Apr 201371816
May 2013511616
Jun 2013351324
Jul 201354713
Aug 2013361519
Sep 201336615
Oct 201354611
Nov 201324911
Dec 2013341023
Jan 2014192324
Feb 2014262223
Mar 2014252119
Apr 2014182022
May 2014231612
Jun 2014102413
Jul 2014202016
Aug 201422922
Sep 2014133432
Oct 2014182829
Nov 2014233314
Dec 2014241813
Jan 2015183721
Feb 2015152410
Mar 2015283213
Apr 2015202610
May 2015182311
Jun 2015192710
Jul 2015191818
Aug 2015281713
Sep 201522106
Oct 201510187
Nov 2015171810
Dec 201512166
Jan 2016311419
Feb 2016131716
Mar 2016361828
Apr 2016252413
May 2016121815
Jun 201692518
Jul 2016223915
Aug 2016274215
Sep 201672810
Oct 20161118536
Nov 201665229
Dec 201614414
Jan 201714725
Feb 201704923
Mar 201725117
Apr 201714020
May 201713628
Jun 201714633
Jul 201713424
Aug 201723613
Sep 20179338
Oct 201703014
Nov 201743319
Dec 20174248
Jan 201823122
Feb 20182329
Mar 20181198
Apr 201874824
May 201833422
Jun 201801714
Jul 201821317
Aug 2018413421
Sep 2018012917
Oct 201874219
Nov 201809325
Dec 2018501335
Jan 201948513
Feb 20193969
Mar 20191724
Apr 201929612
May 2019151617
Jun 201932820
Jul 20192147
Aug 201938712
Sep 20194088
Oct 20193148
Nov 20193659
Dec 20191763
Jan 20201561
Feb 202039810
Mar 20201023
Apr 202016114
May 20201014
Jun 20201924
Jul 20201403
Aug 20201537
Sep 20201461
Oct 202028610
Nov 20201689
Dec 20202427
Jan 202144135
Feb 202125226
Mar 20213033
Apr 20213152
May 202133146
Jun 202127105
Jul 20213353
Aug 20213693
Sep 202117134
Oct 20212061
Nov 20211747
Dec 20214343
Jan 20224385
Feb 20223587
Mar 20224027
Apr 20221832
May 20223947
Jun 2022241010
Jul 202221812
Aug 20221998
Sep 20222644
Oct 202231168
Nov 202225210
Dec 20222673
Jan 202331145
Feb 2023010

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 82 (6)
Molecular Pharmacology
Vol. 82, Issue 6
1 Dec 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Generation and Characterization of Novel Cytochrome P450 Cyp2c Gene Cluster Knockout and CYP2C9 Humanized Mouse Lines
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Cyp2c Knockout and CYP2C9 Humanized Mice

Nico Scheer, Yury Kapelyukh, Lynsey Chatham, Anja Rode, Sandra Buechel and C. Roland Wolf
Molecular Pharmacology December 1, 2012, 82 (6) 1022-1029; DOI: https://doi.org/10.1124/mol.112.080036

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Cyp2c Knockout and CYP2C9 Humanized Mice

Nico Scheer, Yury Kapelyukh, Lynsey Chatham, Anja Rode, Sandra Buechel and C. Roland Wolf
Molecular Pharmacology December 1, 2012, 82 (6) 1022-1029; DOI: https://doi.org/10.1124/mol.112.080036
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The binding site for KCI807 in the androgen receptor
  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics